NPPTL COVID-19 Response, International Assessment-Not NIOSH Approved, Hangzhou Biopharmaceutical National High-tech Industrial Base Investment Management Co., Ltd., Model 9501

i

NPPTL COVID-19 Response, International Assessment-Not NIOSH Approved, Hangzhou Biopharmaceutical National High-tech Industrial Base Investment Management Co., Ltd., Model 9501

Public Domain

07/30/2020

Details

Description:

These findings pertain to the Hangzhou Biopharmaceutical National High-tech Industrial Base Investment Management Co., Ltd., Model 9501. The packaging for this product indicates that it meets GB2626-2006 standards.
Document Type:

Report
CIO:

NIOSH
Division:

NIOSH_NPPTL
NIOSHTIC Number:

nn:na
Collection(s):

National Institute for Occupational Safety and Health
Main Document Checksum:

urn:sha-512:c0c258b34c27b4adfcb66bff661a1cab792f2b702a775d6d796fdc41f0557ca85af070c91f4b5fb0044f1ef293a98f4bbf5ecf77626cd2d1588ce3c6f4c5bd5a
Download URL:

https://stacks.cdc.gov/view/cdc/137950/cdc_137950_DS1.pdf
File Type:

[PDF - 2.60 MB ]

ON THIS PAGE

Details

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.